Skip to content
Unrated Drug recall · FDA · Published July 14, 2026

Precision Dose Glycopyrrolate Oral Solution Recall: Impurities Risk

Precision Dose recalls Glycopyrrolate Oral Solution (1 mg/5 mL) due to failed impurities and degradation specifications. This prescription medication may pose risks if used as intended.

🇺🇸 FDA recall #D-0741-2026DrugPrecision Dose ›
✎ GovInfoNow plain-language explainer

Precision Dose is recalling a prescription-strength Glycopyrrolate Oral Solution (1 mg/5 mL) because it failed impurities and degradation tests. This could mean the medication is unsafe for use as intended. Read more at govinfonow.com/recall/309294-precision-dose-glycopyrrolate-oral-solution-recall-impurities-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/309294-precision-dose-glycopyrrolate-oral-solution-recall-impurities-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0741-2026

Cite this page

“Precision Dose Glycopyrrolate Oral Solution Recall: Impurities Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/309294-precision-dose-glycopyrrolate-oral-solution-recall-impurities-risk. Based on FDA recall #D-0741-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0741-2026%22&limit=1).

The FDA announced on July 14, 2026, that Precision Dose Inc. is recalling Glycopyrrolate Oral Solution due to failed impurity specifications. The agency issued recall number D-0741-2026 for the voluntary Class II action.

How to tell if you have it

  • Brand: Precision Dose
  • Product: Glycopyrrolate Oral Solution, 1 mg/5 mL
  • NDCs: 68094-073-01 (oral syringe) and 68094-073-58 (case)
  • Lot #: 506033
  • Expiration Date: 11/30/2026

The hazard

The recall addresses failed impurities and degradation specifications in the product. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Precision Dose Inc. has had six other recalls since March 21, 2013. Other recent recalls of similar products include Novadoz Glycopyrrolate Oral Solution Recall (Dec. 15, 2025), SUN PHARMACEUTICAL Clindamycin Phosphate Topical Solution Recall (Nov. 26, 2025), and Somerset Therapeutics Dexamethasone Injection Recall (Feb. 4, 2026).

How to tell if you have this one

Check for the product name 'Glycopyrrolate Oral Solution', 1 mg/5 mL, with NDC codes 68094-073-01 (syringe) or 68094-073-58 (case). Look for lot number 506033 or expiration date 11/30/2026.

  • Brand
    Precision Dose
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the NDC codes and expiration date to confirm if your product is affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 15 days after the firm started it.

1. Firm started the recall: Jul 14, 202612. Published in FDA’s Enforcement Report: Jul 29, 202623. FDA classified it Class II: Aug 5, 202634. Added to GovInfoNow: Aug 18, 202642026
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class II
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this medication safe to use?

The recall states the product failed impurities and degradation specifications, so it may not be safe. Do not use this product without confirming it's not recalled.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0741-2026 (July 14, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0741-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA